GlassScriptPhysician profile
Maria M Belean
NPI 1023334745
$3,862.04
in general payments reported to CMS, 2019-2025
36 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $755 · 2022: $465 · 2023: $671 · 2024: $620 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,641.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $678.88 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $540.20 | 2021-2025 | |
| Janssen Biotech, INC. | $385.29 | 2024-2025 | Erleada, Rybrevant, Carvykti |
| Verity Pharmaceuticals INC. | $339.77 | 2021-2025 | Tlando, Trelstar |
| Bayer Healthcare Pharmaceuticals INC. | $181.13 | 2023-2025 | |
| Procept Biorobotics Corporation | $169.16 | 2022-2025 | |
| Tolmar, INC. | $124.18 | 2023-2025 | Eligard, Jatenzo |
| Rochester Medical Corporation | $118.74 | 2021 | |
| Endo USA, INC. | $110.79 | 2024-2025 | Xiaflex |
| Boston Scientific Corporation | $102.57 | 2022-2025 | Lithovue Elite, Rezum Generator, Axonics |
| Halozyme INC | $95.66 | 2023 | |
| Mission Pharmacal Company | $94.50 | 2021-2024 | Lithostat, Uribel Tabs |
| Endo Pharmaceuticals INC. | $86.47 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $75.72 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $67.76 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $65.14 | 2021-2025 | Urolift |
| Myovant Sciences INC. | $62.81 | 2021 | |
| Biotissue Holdings INC. | $61.19 | 2023-2025 | |
| Coherus Oncology, INC. | $48.48 | 2023 | |
| Accord Healthcare, INC. | $44.79 | 2025 | |
| Clarus Therapeutics INC. | $42.61 | 2021 | |
| Coloplast Corp | $42.04 | 2024 | |
| Calyxo, INC. | $30.02 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $29.48 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $26.84 | 2023 | Lynparza, Keytruda |
| Urogen Pharma, INC. | $25.29 | 2023 | Jelmyto |
| Telix Pharmaceuticals | $25.29 | 2023 | Illuccix |
| Axonics, INC. | $24.56 | 2023 | Axonics |
| Foundation Medicine, INC. | $23.60 | 2022 | |
| Agiliti Surgical, INC. | $22.85 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Astellas Pharma US INC | $22.12 | 2021 | |
| Blue Earth Diagnostics | $22.07 | 2024 | |
| Laborie Medical Technologies Corp. | $21.45 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Becton, Dickinson and Company | $19.38 | 2024 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $18.60 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Belean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.